Infectious diseases specialty intervention is associated with decreased mortality and lower healthcare costs.
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Previous studies, largely based on chart reviews with small sample sizes, have demonstrated that infectious diseases (ID) specialists positively impact patient outcomes. We investigated how ID specialists impact mortality, utilization, and costs using a large claims dataset. METHODS: We used administrative fee-for-service Medicare claims to identify beneficiaries hospitalized from 2008 to 2009 with at least 1 of 11 infections. There were 101 991 stays with and 170 336 stays without ID interventions. Cohorts were propensity score matched for patient demographics, comorbidities, and hospital characteristics. Regression models compared ID versus non-ID intervention and early versus late ID intervention. Risk-adjusted outcomes included hospital and intensive care unit (ICU) length of stay (LOS), mortality, readmissions, hospital charges, and Medicare payments. RESULTS: The ID intervention cohort demonstrated significantly lower mortality (odds ratio [OR], 0.87; 95% confidence interval [CI], .83 to .91) and readmissions (OR, 0.96; 95% CI, .93 to .99) than the non-ID intervention cohort. Medicare charges and payments were not significantly different; the ID intervention cohort ICU LOS was 3.7% shorter (95% CI, -5.5% to -1.9%). Patients receiving ID intervention within 2 days of admission had significantly lower 30-day mortality and readmission, hospital and ICU length of stay, and Medicare charges and payments compared with patients receiving later ID interventions. CONCLUSIONS: ID interventions are associated with improved patient outcomes. Early ID interventions are also associated with reduced costs for Medicare beneficiaries with select infections.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Specialist consultation appears to be associated with improved patient outcomes for a variety of infectious syndromes [295–300].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [298]
Citations
Cites
Porter, M. E. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1011024 · Cited by 5,084
Jenkins, T. C., Price, C. S., Sabel, A. L., Mehler, P. S., & Burman, W. J. (2008) · Clinical Infectious Diseases · doi:10.1086/529190 · Cited by 216
The Value of Infectious Diseases Consultation in Staphylococcus aureus Bacteremia
Honda, H., Krauss, M. J., Jones, J. C., Olsen, M. A., & Warren, D. K. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.01.015 · Cited by 189
Rieg, S., Peyerl-Hoffmann, G., de With, K., Theilacker, C., Wagner, D., Hübner, J., Dettenkofer, M., Kaasch, A., Seifert, H., Schneider, C., et al. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.07.015 · Cited by 181
Kaech, C., Elzi, L., Sendi, P., Frei, R., Laifer, G., Bassetti, S., & Flückiger, U. M. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01359.x · Cited by 174
Infectious Diseases Consultation Lowers Mortality From Staphylococcus aureus Bacteremia
Lahey, T., Shah, R., Gittzus, J., Schwartzman, J. D., & Kirkland, K. B. (2009) · Medicine · doi:10.1097/md.0b013e3181b8fccb · Cited by 143
Smetana, G. W. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.1.10 · Cited by 131 · cited 2×
“Unobserved characteristics about the healthcare setting in which the ID specialist operates, including the availability of key information or medical technology and care management programs, and variability in medical practice of ID or non-ID physicians could impact outcomes [12].”
The Value of an Infectious Diseases Specialist
Petrak, R. M., Sexton, D. J., Butera, M., Tenenbaum, M. J., MacGregor, M. C., Schmidt, M. E., Joseph, W. P., Kemmerly, S. A., Dougherty, M. J., Bakken, J., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/374245 · Cited by 121
Self-citationRobinson, J. O., Langhi, S., Phillips, M. R., Pearson, J. C., Christiansen, K., Coombs, G. W., & Murray, R. J. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1585-y · Cited by 106
The Value of Infectious Diseases Specialists: Non–Patient Care Activities
McQuillen, D. P., Petrak, R. M., Wasserman, R. B., Nahass, R., Scull, J. A., & Martinelli, L. P. (2008) · Clinical Infectious Diseases · doi:10.1086/592067 · Cited by 83
Self-citationEarly Discharge of Infected Patients Through Appropriate Antibiotic Use
Eron, L. J., & Passos, S. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.1.61 · Cited by 82
Clinical Impact of an Infectious Disease Service on the Management of Bloodstream Infection
Flückiger, U. M., Zimmerli, W., Sax, H., Frei, R., & Widmer, A. F. (2000) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960000306 · Cited by 80
Gómez, J., Gómez, J., Cavero, S. J. C., et al. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/38.2.309 · Cited by 69
30-Day Survival and Rehospitalization for Stroke Patients According to Physician Specialty
Smith, M. A., Liou, J., Frytak, J. R., & Finch, M. D. (2006) · Cerebrovascular Diseases · doi:10.1159/000092333 · Cited by 68
Classen, D. C., Burke, J. P., & Wenzel, R. P. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.3.468 · Cited by 56
Fox, B. C., Imrey, P. B., Voights, M. B., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/324083 · Cited by 47
Borer, A., Moran‐Gilad, J., Meydan, N., et al. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00964.x · Cited by 27
Lundberg, J., Nettleman, M. D., Costigan, M., et al. (1998) · PubMed · Cited by 20
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Norris, A. H., Shrestha, N. K., Allison, G. M., Keller, S. C., Bhavan, K. P., Zurlo, J. J., Hersh, A. L., Gorski, L. A., Bosso, J. A., Rathore, M. H., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy745 · Cited by 372
Self-citationThorpe, K. E., Joski, P., & Johnston, K. J. (2018) · Health Affairs · doi:10.1377/hlthaff.2017.1153 · Cited by 253
Madaline, T., Wadskier Montagne, F., Eisenberg, R., Mowrey, W., Kaur, J., Malik, M., Gendlina, I., Guo, Y., White, D., Pirofski, L.-A., et al. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz408 · Cited by 43
Metadata
- Authors
- Schmitt, S., McQuillen, D. P., Nahass, R., Martinelli, L., Rubin, M., Schwebke, K., Petrak, R., Ritter, J. T., Chansolme, D., Slama, T., Drozd, E. M., Braithwaite, S. F., Johnsrud, M., & Hammelman, E.
- Affiliations
- Cleveland Clinic (US)
- Tufts University (US)
- Covenant Health System (US)
- University of Utah (US)
- Optum (United States) (US)
- Indiana University School of Medicine (US)
- Corresponding author
- Schmitt, Steven
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-09-25
- Volume
- 58
- Issue
- 1
- Pages
- 22-28
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2146352833
- Cited by
- 195
- References
- 18
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 8 · 2023: 5 · 2022: 13 · 2021: 14 · 2020: 24 · 2019: 17 · 2018: 25 · 2017: 21 · 2016: 19 · 2015: 21 · 2014: 16 · 2013: 1
- FWCI
- 16.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
- Keywords
- infectious disease specialists, in-hospital mortality, hospital readmission, length of hospital stay, health care costs, Medicare, intensive care unit, infection hospitalization, timing of care
- MeSH terms
- Aged, Aged, 80 and over, Communicable Diseases, Cross Infection, Female, Humans, Length of Stay, Male, Middle Aged, Survival Analysis, Health Care Costs, Infection Control
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.